[1] Miyasaka Y, Uno Y, Kazut Yoshimi K, et al. CLICK: one-step generation of conditional knockout mice. BMC Genomics, 2018, 19(1): 318. [1] Dallas SL, Xie Y, Shiflett LA, et al. Mouse Cre models for the study of bone diseases. Curr Osteoporos Rep, 2018,16(4): 466-477. [2] Elefteriou F, Couasnay G. Advantages andlimitations of Cre mouse lines used in skeletal research. Methods Mol Biol, 2021,2230: 39-59. [3] Kim H, Kim M, Im SK, et al. Mouse Cre-LoxP system: general principles to determine tissue-specific roles of target genes. Lab Anim Res, 2018,34(4): 147-159. [4] Kos CH. Cre/loxP system for generating tissue-specific knockout mouse models. Nutr Rev, 2004,62(6 Pt 1): 243-246. [5] Pompili V, Dalla Costa L, Piazza S, et al. Reduced fire blight susceptibility in apple cultivars using a high-efficiency CRISPR/Cas9-FLP/FRT-based gene editing system. Plant Biotechnol J, 2020, 18(3): 845-858. [6] Hara T, Verma IM. Modelinggliomas using two recombinases. Cancer Res, 2019, 79(15): 3983-3991. [7] Tamura S, Yasuoka Y, Miura H, et al. Thy1 promoter activity in the Rosa26 locus in mice: lessons from Dre-rox conditional expression system. Exp Anim, 2020, 69(3): 287-294. [8] Soni A, Augsburg M, Buchholz F, et al. Nearest-neighbor amino acids of specificity-determining residues influence the activity of engineered Cre-type recombinases. Sci Rep, 2020, 10(1): 13985. [9] Konno T, Kohno T, Okada T, et al. ASPP2 suppression promotes malignancy via LSR and YAP in human endometrial cancer. Histochem Cell Biol, 2020, 154(2):197-213. [10] Xiao S, Wang R, Wu X, et al. Thelong noncoding RNA TP73-AS1 interacted with miR-124 to modulate glioma growth by targeting inhibitor of apoptosis- stimulating protein of p53. DNA Cell Biol, 2018, 37(2): 117-125. [11] Richter AM, Küster MM, Woods ML, et al. RASSF10is a TGF beta-target that regulates ASPP2 and E-cadherin expression and acts as tumor suppressor that is epigenetically downregulated in advanced cancer. Cancers (Basel), 2019, 11(12): 1976. [12] Liang B, Chen R, Song S, et al. ASPP2 inhibits tumor growth by repressing the mevalonate pathway in hepatocellular carcinoma. Cell Death Dis, 2019, 10(11): 830. [13] Ji J, Zhou X, Xu P, et al. Deficiency of apoptosis-stimulating protein two of p53 ameliorates acute kidney injury induced by ischemia reperfusion in mice through upregulation of autophagy. J Cell Mol Med, 2019, 23(4): 2457-2467. [14] Lin M, Chang Y, Xie F, et al. ASPP2inhibits the profibrotic effects of transforming growth factor-beta1 in hepatic stellate cells by reducing autophagy. Dig Dis Sci, 2018, 63(1): 146-154. [15] Liu X, Xu J, Wang S, et al. Synergistic inhibitory effects on hepatocellular carcinoma with recombinant human adenovirus Aspp2 and oxaliplatin via p53-independent pathway in vitro and in vivo. Int J Oncol, 2017,51(4): 1291-1299. [16] 刘晓霓, 寇卜心, 柴梦音, 等. ASPP2基因敲除小鼠的构建及对DEN诱导肝癌的影响.中华肝脏病杂志, 2020, 28(9): 784-789. [17] Wang S, Kou B, Chai M, et al. Knockout of ASPP2 promotes DEN-induced hepatocarcinogenesis via the NF-kappaB pathway in mice. Cancer Gene Ther, 2021[ahead of print]. [18] Alhassen L, Phan A, Alhassen W, et al. The role of Olfaction in MCH-regulated spontaneous maternal responses. Brain Res, 2019, 1719: 71-76. [19] Young KG, Yan K, Picketts DJ. C3aR signaling and gliosis in response to neurodevelopmental damage in the cerebellum. J Neuroinflammation, 2019, 16(1): 135. [20] 陈明发, 吴夏, 幼辰, 等. CXCR3基因敲除小鼠慢性乙型肝炎病毒复制模型的建立.实用肝脏病杂志, 2012, 15 (4): 332-335. |